Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04416126Phase 1Completed
Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
Ornithine Transcarbamylase Deficiency
PrincipalinvestigatorStart date: 2020-06-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Auckland Clinical Studies (ACS) Ltd.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Martina Huemer

University Children's Hospital, Zurich

Moderately Similar
1 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Andrea L Gropman, M.D.

Children's National Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Lyazzat M. Syrlybayeva, MD

West Kazakhstan Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Steven E. Raper

University of Pennsylvania

Moderately Similar
1 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Gloria Wong, MD

Q-Pharm Pty Ltd

Moderately Similar
1 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Peter J McGuire, M.D.

National Human Genome Research Institute (NHGRI)

Moderately Similar
2 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Lindsay Burrage, MD, PhD

Baylor College of Medicine

Moderately Similar
2 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

George Diaz, M.D., Ph.D

iECURE, Inc.

Moderately Similar
2 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Mendel Tuchman, MD

Children's National Research Institute

Moderately Similar
4 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Margreet Wagenmakers

Erasmus Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Ornithine Carbamoyltransferase Deficiency Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04416126Phase 1PrincipalInvestigator

Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects

Ornithine Transcarbamylase Deficiency
Completed

All 1 trials loaded